S.No. |
Product |
| |
YEAR 2010 |
65 |
Chimeric monoclonal antibody (IgG1k) Abciximab |
64 |
Palivizumab |
63 |
Pandemic H1N1 and seasonal trivalent influenza VLP vaccines. |
62 |
Human Granulocyte Colony Stimulating Factor (rh G-CSF) |
61 |
Anti Rho (D) immunoglobulin |
60 |
Human Insulin API (r-DNA origin) |
59 |
Salmonella typhi strain expressing HPV18 L1 and HPV16 L1 VLPs for Oral Vaccine |
58 |
Human Chorionic Gonadotropin (rHCG) |
57 |
Human B-type Natriuretic peptide (rhBNP, VB17) |
56 |
BioChaperone 1 (PDGF-BB+DMCTrp) |
|
YEAR 2009 |
55 |
Human Interferon gamma-1b (IFNg) |
54 |
Human Parathyroid Hormone (rHu PTH) |
53 |
Combination Malaria Vaccine Composed of Recombinant PfMSP-119 and PfF2 |
52 |
Darbepoetin-alpha |
51 |
Etanercept (TNFr-antibody fusion protein) |
50 |
Teriparatide (rDNA origin) Injection (750 mcg/vial) |
49 |
Human Follicle Stimulating Hormone (rFSH) |
48 |
Human Platelet Derived Growth Factor-BB (PDGF-BB) |
47 |
Human Interleukin 2 (r-hu-IL-2) |
|
YEAR 2008 |
46 |
Bevacizumab |
45 |
Trastuzumab |
44 |
Human Parathyroid Hormone (rhPTH1-34) |
43 |
THR-100 (recombinant staphylokinase) |
42 |
Hepatitis B antigen in novel formulation |
41 |
Tetravalent vaccines (DPT+HEP-B)
|
40 |
Pegylated Human IFN alpha- 2b [PegIFN alpha2b]
|
39 |
Urate Oxidase (VB 37)
|
38 |
Anti Rabies Human Monoclonal Antibody (SII RMab) |
|
YEAR 2007 |
37 |
Human G-CSF |
36 |
Somatropin |
35 |
Pegylated recombinant methionyl human Granulocyte Colony Stimulating Factor (PEG-r-met hu G-CSF) |
34 |
rh-Tissue Plasminogen Activator (tPA) |
33 |
Polysialated Erythropoietin |
32 |
Darbopoetin
|
31 |
Nesiritide
|
30 |
Insulin Glargine
|
29 |
IN-105 (Oral insulin)
|
|
YEAR 2006 |
28 |
Human tissue Plasminogen Activator (rh-TPA) |
27 |
Pegylated r-h-erythropoietin |
26 |
Pentavalent vaccine (Diphtheria, Tetanus, Pertusis, recombinant Hepatitis B and Haemophilus influenzae type B conjugate vaccine) |
25 |
Rituximab (monoclonal antibody) |
24 |
“BIOMAb EGFR” Humanized Anti-EGFR monoclonal antibody: Generic name Nimotuzumab injection) and Nimotuzumab-Bulk BIOMAb EGFR™-Bulk. |
23 |
Monoclonal Tetanus Immunoglobulin |
22 |
Human MAB RM1 IgGI.k |
21 |
Human Granulocyte Colony Stimulating Factor (rh-G-CSF) |
20 |
Hepatitis B antigen |
19 |
Clinical evaluation of Relivax-DC for immunotherapy of prostate cancer |
18 |
Tetravalent combination vaccine (DPT-r-Hepatitis B) and pantavalent combination vaccine (DPT-r-Hepatitis B + HIB) |
17 |
Human Interferon alpha 2b (rh-IFNá2b) |
16 |
Human Erythropoietin (rh-EPO) |
|
YEAR 2005 |
15 |
Pegylated Granulocyte Colony Stimulating Factor (r-h-peg-G-CSF) |
14 |
Lysostaphin gel |
13 |
Granulocyte Colony Stimulating Factor (r-h-G-CSF) |
12 |
streptokinase |
11 |
Human Granulocyte-Macrophase Colony Stimulating Factor (r-hu-GM-CSF) |
10 |
Pegylated Human Interferon Alfa 2b |
9 |
Pentavalent combination vaccine consisting of Diphtheria, Tetanus, whole cell Pertussis, r-Hepatitis B & Hemophilus Influenzae type B (DTwPH-Hib) |
8 |
TNK-t-PA |
7 |
Human Follicle Stimulating Hormone (rh-FSH) |
6 |
Interferon a2a |
5 |
pegylated Interferon a2a |
4 |
Interferon a2b |
3 |
Pegylated Interferon a2b |
2 |
Human interferon alpha 2b (rh-IFN 2b) |
1 |
Erythropoietin |
